Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Curr Drug Metab ; 23(6): 447-459, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35676849

RESUMEN

At present, people and patients worldwide are relying on the medicinal plant as a therapeutic agent over pharmaceuticals because the medicinal plant is considered safer, especially for chronic disorders. Several medicinal plants and their components are being researched and explored for their possible therapeutic contribution to CNS disorders. Thymoquinone (TQ) is one such molecule. Thymoquinone, one of the constituents of Plant Nigella Sativa, is effective against several neurodegenerative diseases like, Alzheimer's, Depression, Encephalomyelitis, Epilepsy, Ischemia, Parkinson's, and Traumatic. This review article presents the neuropharmacological potential of TQ's, their challenges, and delivery prospects, explicitly focusing on neurological disorders along with their chemistry, pharmacokinetics, and toxicity. Since TQ has some pharmacokinetic challenges, scientists have focused on novel formulations and delivery systems to enhance bioavailability and ultimately increase its therapeutic value. In the present work, the role of nanotechnology in neurodegenerative disease and how it improves the bioavailability and delivery of a drug to the site of action has been discussed. There are a few limitations to developing novel drug formulations, including solubility, pH, and compatibility of nanomaterials. Since here we are targeting CNS disorders, the bloodbrain barrier (BBB) becomes an additional challenge. Hence, the review summarized the novel aspects of delivery and biocompatible nanoparticles-based approaches for targeted drug delivery into CNS, enhancing TQ bioavailability and its neurotherapeutic effects.


Asunto(s)
Enfermedades del Sistema Nervioso Central , Enfermedades Neurodegenerativas , Nigella sativa , Plantas Medicinales , Benzoquinonas/farmacología , Benzoquinonas/uso terapéutico , Enfermedades del Sistema Nervioso Central/tratamiento farmacológico , Sistemas de Liberación de Medicamentos , Humanos , Enfermedades Neurodegenerativas/tratamiento farmacológico , Nigella sativa/química
2.
Nat Prod Res ; 35(15): 2569-2573, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31631708

RESUMEN

The present study aimed to explore the biocomponents of Murraya koenigii leaves through hot continuous percolation method using methanol as solvent. The spectral analysis by GC-MS and FTIR study demonstrated the presence of alkaloids, tannins, fatty acids, and steroids. The extract was characterized by the presence of unique compounds such as epiyangambin, stigmasterol, α-terpineol, eucalyptol, ethyl cinnamate, fatty acids, and other steroids.


Asunto(s)
Murraya , Extractos Vegetales/análisis , Hojas de la Planta/química , Metanol/química , Fitoquímicos , Extractos Vegetales/química , Arabia Saudita
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA